作者:
Aslanyan,M.G. [1]
;
Kroeze,L.I. [2]
;
Langemeijer,S.M.C. [3]
;
Koorenhof-Scheele,T.N. [4]
;
Massop,M. [5]
;
VanHoogen,P. [6]
;
Stevens-Linders,E. [7]
;
VanDeLocht,L.T. [8]
;
T?nnissen,E. [9]
;
VanDerHeijden,A. ;
DaSilva-Coelho,P. ;
Cilloni,D. ;
Saglio,G. ;
Marie,J.-P. ;
Tang,R. ;
Labar,B. ;
Amadori,S. ;
Muus,P. ;
Willemze,R. ;
Marijt,E.W.A. ;
DeWitte,T. ;
VanDerReijden,B.A. ;
Suciu,S. ;
Jansen,J.H.
作者单位:
European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium
[1]
Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
[2]
Department of Hematology and Clinical and Biological Sciences, S. Luigi Hospital, University of
[3]
Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical
[4]
Department of Hematology, Tor Vergata University Hospital, Rome, Italy
[5]
Department of Hematology and Tumor Bank, Saint-Antoine Hospital, University Pierre and Marie Curie
[6]
Department of Hematology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
[7]
Department of Tumor Immunology, Radboudumc, Nijmegen, Netherlands
[8]
Department of Hematology, Clinical Institute of Laboratory Diagnosis, University School of Medicine
[9]
发布时间
2014-10-24